Spray Relief for Dry Eyes

• Gives fast, effective comfort to dry eye sufferers
• Revolutionary new spray delivery system
• Simply spray onto your closed eyes
• No more eyedrops or gels
• Ideal for contact lens wearers

Leave your lenses in

There’s no need to remove your lenses before use. Clarymist ™ eye spray is safe to apply while wearing all types of lenses. Use in exactly the same way as non-lens wearers, and you’ll feel almost immediate relief.

Volume: 10ml

Clarymist Benefits

No direct contact, so high level of eye safety
The spray application means there is no danger of injuries caused by bottles or tubes touching the eye. Also there is no possibility of an overdose occurring.

Hygienic delivery, simple spray action
As there is no direct contact with the eye or hands there is no chance of cross contamination. That also means the same aerosol can safely be used at home by all the family, or in the office it is safe to lend to a colleague in trouble with dry eye.

Comfortable in use
With other products a burning effect is often experienced on application, but not with Clarymist ™ eye spray. Although for some there may be an initial sensation, this will quickly disappear. There is no agent actually contacting the eye surface directly, as the eye is initially shut. A sufficient quantity of the lipid ingredients seeps gently between the eyelids and onto the very outer layer of the eye’s tear coating.

Immediate clear view, safe for drivers
With no immediate and direct contact with the eye, there is no blurring or impairing of the vision. That means it is safe for use immediately before driving or operating machinery, and if you are at work you can continue uninterrupted.

Long Life
Clarymist ™ eye spray contains preservatives which assure it of a long life without deterioration. Once openedClarymist ™ eye spray is safe to use up to three years from the date of manufacture – the 'use by' date is marked on both the pack and the bottle.

Clarymist™ Clinical Trials

Trial 1 – Proven effectiveness of Clarymist ™

Stringent Methodology
A study of 382 dry eye sufferers was performed in Stuttgart between August 2003 and May 2004 to test the effectiveness of Clarymist ™ eye spray – at that time marketed in Germany as Tears Again TM. The methodology for the trial was exceptionally stringent, being 'double blind', which means that neither the clinicians nor the volunteer users knew who was taking the real product and who was taking a placebo control. These precautions eliminate the common experimental errors of observer and subject bias, and assure highly reliable findings.

Clearly Demonstrated Effectiveness
At the end of the trial, parameters such as LIPCOF, BUT, and Schirmer were all significantly superior in the treatment group compared to the control group. Other effects included a remarkable reduction of 89.5% in inflammation of the margins of the eyelid. Questioning of the patients revealed a subjective perception of reduced symptoms in 72% of the cases. Also every patient was of the opinion that usingClarymist ™ eye spray is more straightforward and more pleasant than tear substitute eye drops.

Reference
These outstanding results achieved were published in the leading German Ophthalmic Journal. (Klin Monatsbl Augenheilkunde 2004;221: 825-836)

Trial 2 – Comparative trial demonstrates efficacy and usability

Positive comparison with eye gel
A further blinded crossover study compared Clarymist ™ eye spray with a triglyceride gel treatment that also addresses the tear film lipid phase. Parameters measured were almost identical to the first study.

The conclusions state thatClarymist ™ eye spray showed statistically significant clinical advantages over the triglyceride tear substitute on all the key measurements. In addition, 96% of the patients stated that they preferred the Clarymist ™ eye spray method of application to the gel system.

Reference
'Comparative study of the therapy of dry eye syndrome with artificial tear substitutes especially for the treatment of the disturbance of the lipid layer.’ Lee S., Dausch D., Dausch S. Klinikum St. Marien, Amberg

Please Note:
This product has been rebranded for the UK and Ireland and is called Clarymist ™.